10X Genomics, Inc. (TXG)
71.55
+1.80
(+2.58%)
USD |
NASDAQ |
Oct 23, 16:00
71.60
+0.05
(+0.07%)
After-Hours: 20:00
10X Genomics Enterprise Value : 8.848B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.848B |
| October 22, 2026 | 8.614B |
| October 21, 2026 | 9.375B |
| October 20, 2026 | 8.837B |
| October 19, 2026 | 8.632B |
| October 16, 2026 | 8.628B |
| October 15, 2026 | 8.958B |
| October 14, 2026 | 9.050B |
| October 13, 2026 | 8.880B |
| October 12, 2026 | 9.323B |
| October 09, 2026 | 10.03B |
| October 08, 2026 | 9.595B |
| October 07, 2026 | 9.441B |
| October 06, 2026 | 10.04B |
| October 05, 2026 | 12.26B |
| October 02, 2026 | 11.71B |
| October 01, 2026 | 11.09B |
| September 30, 2026 | 11.30B |
| September 29, 2026 | 11.26B |
| September 28, 2026 | 11.06B |
| September 25, 2026 | 10.69B |
| September 24, 2026 | 10.48B |
| September 23, 2026 | 9.379B |
| September 22, 2026 | 10.04B |
| September 21, 2026 | 9.832B |
| Date | Value |
|---|---|
| September 18, 2026 | 9.506B |
| September 17, 2026 | 9.555B |
| September 16, 2026 | 8.996B |
| September 15, 2026 | 9.218B |
| September 14, 2026 | 8.661B |
| September 11, 2026 | 8.463B |
| September 10, 2026 | 8.175B |
| September 09, 2026 | 8.293B |
| September 08, 2026 | 8.073B |
| September 04, 2026 | 7.689B |
| September 03, 2026 | 7.763B |
| September 02, 2026 | 7.559B |
| September 01, 2026 | 7.341B |
| August 31, 2026 | 7.663B |
| August 28, 2026 | 7.544B |
| August 27, 2026 | 7.976B |
| August 26, 2026 | 7.899B |
| August 25, 2026 | 7.959B |
| August 24, 2026 | 7.839B |
| August 21, 2026 | 8.011B |
| August 20, 2026 | 7.848B |
| August 19, 2026 | 7.629B |
| August 18, 2026 | 6.774B |
| August 17, 2026 | 7.082B |
| August 14, 2026 | 6.834B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 8.696B |
| Tempus AI, Inc. | 12.80B |
| Intellia Therapeutics, Inc. | 1.205B |
| Personalis, Inc. | 1.511B |
| Alamar Biosciences, Inc. (California) | 1.931B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.93M |
| Revenue (Quarterly) | 151.04M |
| Total Expenses (Quarterly) | 168.97M |
| EPS Diluted (Quarterly) | -0.138 |
| Gross Profit Margin (Quarterly) | 74.36% |
| Profit Margin (Quarterly) | -11.87% |
| Earnings Yield | -0.82% |
| Normalized Earnings Yield | -0.8407 |